Back to search

Netherlands· NL-f537c5e2b050

DRETACEN 1000 mg, filmomhulde tabletten

A levetiracetam product containing levetiracetam, registered in Netherlands by Sandoz B.V.. The same ATC class is registered in 19 of our 19 countries.

ATC N03AX14

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedDRETACEN 1000 mg, filmomhulde tablett…ATCN03AX14REGISTER NO.NL-f537c5e2b050PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Levetiracetam is registered in 19 of 19 countries.

Countries holding a registration under ATC N03AX14 (levetiracetam), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 11 of them publish a price we can compare per daily dose

Levetiracetam · ATC N03AX14

19 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of levetiracetam costs, country by country.

Normalised to the WHO defined daily dose (1.5 g), the median price runs from $1.19 in France to $3.10 in Spain — a ×2.6 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Levetiracetam · price per daily dose (1.5 g)

USD · FX 28 Sept 2026

  • ES Spain$3.10
  • CH Switzerland$2.54
  • IT Italy$2.14
  • FR France$1.19
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
LEVETIRACETAM
Manufacturer
Sandoz B.V.
Country
Netherlands (NL)
ATC code
N03AX14
ATC class
Levetiracetam
Defined daily dose
1.5 g, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    108565

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

258 interactions on record for levetiracetam.

Graded by severity as the source publishes them — 50 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Levetiracetam · interactions on record

258 records

  • 50 moderate
  • 3 minor
  • 164 info

Most severe, free to view

  • MetoclopramideA03FA01moderate
  • DiphenhydraminA04AB05moderate
  • DronabinolA04AD10moderate
  • NabiloneA04AD11moderate

41 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Levetiracetam in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All levetiracetam products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Levebon, Levetiracetam +pharma
  • Belgium · Larofec, Levetiracetam A.Forall
  • Bulgaria · Levebon, Леветиракон Pharmacons
  • Cyprus · Levetiracetam Noridem, Lyberen
  • Czechia · Dretacen, Epiletam
  • Germany · Levetiracetam 1 A Pharma, Levetiracetam Aaa
  • Denmark · Kevesy, Levetiracetam ”1a Farma”
  • Estonia · Levetiracetam Zentiva, Normeg
  • Spain · Laurak, Levetiracetam Almus
  • Finland · Larofec, Levetiracetam 1a Farma
  • France · Levetiracetam Accord, Levetiracetam Aguettant
  • United Kingdom (Northern Ireland) · Desitrend, Genlev
  • Greece · Ession, Kepricet
  • Croatia · Levetiracetam Kalceks, Lyvam
  • Hungary · Epiletam, Levetiracetam Kabi
  • Ireland · Larofec, Levetiracetam Brillpharma
  • Iceland · Keppra, Levetiracetam Accord
  • Italy · Epitiram, Grifoxina
  • Liechtenstein · Keppra, Levetiracetam Accord
  • Lithuania · Dretacen, Levetiracetam Kalceks
  • Luxembourg · Larofec, Levetiracetam Micro Labs
  • Latvia · Levetiracetam Kalceks
  • Malta · Levetiracetam Accord, Levetiracetam Aurobindo
  • Norway · Keppra, Larofec
  • Poland · Cezarius, Lepsitam
  • Portugal · Cinaz, Laurak
  • Romania · Levetiracetam Accord, Levetiracetam Arena
  • Sweden · Levebon, Levetiracetam
  • Slovenia · Levetiracetam Kalceks
  • Slovakia · Epiletam, Levetiracetam

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/7c691645-ce76-47df-a5aa-cb4a56dd3674
GET /v1/drugs/7c691645-ce76-47df-a5aa-cb4a56dd3674?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h108565_smpc_en.pdf",
  "strength": null,
  "atc_label": "Levetiracetam",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg108565",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "CROSPOVIDON (E 1202)",
    "HYPROLOSE (E 463)",
    "HYPROMELLOSE (E 464)",
    "MACROGOL 600",
    "MAGNESIUMSTEARAAT (E 470b)",
    "POVIDON K 25 (E 1201)",
    "SILICIUMDIOXIDE (E 551)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "LEVETIRACETAM"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h108565_piluk.pdf",
  "authorised_at": "2011/09/21",
  "procedure_number": "NL/H/2155/004",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "108565",
  "additional_monitoring": "N"
}

See everything about levetiracetam.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.